Key-confirmable
A task number and verification key are published and can be checked through the named laboratory's route.
Publishing standard
How Remy Research evaluates COA evidence
Remy Research publishes batch-specific evidence only when a reader can trace the claim to a named laboratory report, a stable batch identifier and, when provided by the laboratory, a task number and verification key. Publisher relationships are disclosed so evidence can be weighed with the correct context.
For in-vitro laboratory research only. Not for human or veterinary use.
Ownership and independence
Remy Research shares an operator with the sister research publisher Remy Peptides. It is not an independent company or laboratory. The laboratory reports published here are produced independently by the named laboratory—currently Janoshik Analytical. Remy Research selects, compiles and explains those records.
Neither property supplies research materials. Remy Research publishes no prices, stock records, delivery terms, checkout, payment instructions or order intake; the sister publisher Remy Peptides maintains the wider cited reference library on retatrutide and the incretin literature.
Verification workflow
Match the identity
Record the compound, format and printed batch identifier. A report without a matching batch identifier is not treated as batch-specific product evidence.
Record the laboratory provenance
Capture the named laboratory, analysis date, task number and verification key exactly as displayed on the report.
Check the laboratory route
Use the laboratory's own verification form where available. A mirrored image alone is supporting access, not independent verification.
Separate the measurements
HPLC purity, quantitative assay, heavy metals, TFA and bacterial endotoxin are distinct tests. One result is never presented as proof of another.
Publish limitations and relationships
Each record states what was measured, what was not measured, and whether an exact format relationship is documented.
Evidence states
Report-published
A report is publicly accessible, but the available record may not expose every verification field.
Claim only
A purity or testing claim is stated without a public batch report or reproducible verification route. It is not treated as equivalent evidence.
What HPLC purity means
HPLC separates detectable components under a defined chromatographic method. A reported purity percentage is therefore a relative chromatographic result for that method and sample. It does not automatically equal absolute peptide content, and a retention-time match alone is not conclusive identity evidence.
FDA's ICH Q6A guidance distinguishes identification, assay and impurity procedures and notes that identification by one chromatographic retention time is not sufficiently specific.
HPLC purity vs peptide assay
Purity describes the relative chromatographic composition observed by the method. Assay or concentration estimates how much analyte is present against a validated reference or calibration model. A sample can report high relative purity while its measured content differs from the nominal label, so Remy Research records these as separate fields.
The final ICH Q2(R2) analytical-validation guideline separately addresses identification, assay, purity and impurity tests and the validation characteristics required for their intended use.
What mass spectrometry confirms
Mass spectrometry can support identity by comparing measured mass or fragmentation data with the expected analyte. It is orthogonal to chromatographic purity, but its conclusion still depends on the stated method and reference. If no MS result is published for a batch, this library marks MS identity as “not published” rather than inferring it from HPLC.
What a COA does not prove
A COA documents only the sample, tests, methods and results it names. HPLC purity does not establish sterility, identity by itself, concentration by itself, absence of residual solvents, or suitability for human or veterinary use. Endotoxin, heavy-metals, TFA and microbial-limits results are separate analytical measurements; a partial panel must not be described as a complete panel.
FDA's ICH Q7A guidance describes the expected batch, test, acceptance-limit and numerical-result fields on authentic certificates of analysis. Remy Research uses those fields as an evidence checklist, not as a claim of regulatory approval or GMP status.
How to verify task and key records
- Open the named laboratory's own verification route rather than relying on a mirrored screenshot.
- Enter the published verification key and confirm the task number.
- Match the batch or sample label, analysis date, test type and numerical result.
- Record which tests are absent; do not treat an omitted test as a pass.
- Use the change log and dataset version to check whether the record was corrected later.
Corrections and update policy
Records are corrected when a source report, batch relationship, task number, key, measurement or date is shown to be inaccurate. Material corrections are listed in the public evidence change log; the dataset version and modification date advance with each material release.
Citation and reuse
Cite the exact evidence page and name the original laboratory for laboratory measurements. The compiled dataset metadata is available under CC BY 4.0; laboratory report images and PDFs retain the rights of their original producers and are not relicensed by Remy Research.